Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Billionaire Warren Buffett has said many wise things over the past half a century, including a thing or two about dividend ...

The BBC investigates possible scenarios for the huge Arctic territory's future as the US president-elect talks about taking ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

These companies have track records of success, increasing dividends, and fantastic growth prospects, making them all ideal ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...